ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1153

Rheumatic Manifestations of Whim Syndrome

Ananta Subedi1, Shubhasree Banerjee1, Blas Betancourt1, James D. Katz1, Peter C. Grayson1, Elena Cho2, Daniel Velez2, Philip M. Murphy2 and David H. McDermott2, 1National Institute of Arthritis, Musculoskeletal and Skin Disease (NIAMS), Bethesda, MD, 2National Institute of Allergy and Infectious Diseases (NIAID), Bethesda, MD

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: arthritis and inflammatory arthritis, Case Report

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 6, 2017

Title: Miscellaneous Rheumatic and Inflammatory Diseases Poster I

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: WHIMS (Warts, Hypogammaglobulinemia, Infections, and Myelokathexis Syndrome) is a rare autosomal dominant primary immunodeficiency due to gain of function mutations of the CXC chemokine receptor 4 (CXCR4). CXCR4 signaling is crucial in hematopoietic stem cell homeostasis, and plays an important role in innate and adaptive immune responses. The disease often manifests with recurrent bacterial infections and Human Papilloma Virus (HPV)-induced warts of the hand, feet and genitals. The focus of our study is to characterize the rheumatological manifestations in WHIMS patients.

Methods: Nine patients out of 36 diagnosed with WHIM syndrome enrolled in a treatment protocol were assessed. These 9 patients were identified owing to rheumatological complaints. Demographics, clinical presentation, laboratory data and imaging studies were tabulated to look for common characteristics and patterns of presentation.

Results: The majority of our cohort had onset of rheumatological complaints as children or young adults. Six out of nine were female. The spectrum of initial complaints ranged from arthralgia to overt arthritis. The pattern of joint involvement included asymmetric or symmetric oligo- or polyarthritis involving small and large joints. Three patient exhibited symptoms after a known trigger. In one case, an Oligoarticular small and large joint arthritis postdated a positive urethral chlamydia PCR. Three patients had presentation satisfying a retrospective diagnosis of juvenile idiopathic arthritis. Only one patient had septic arthritis. Another had idiopathic avascular necrosis of the hip in the childhood. We observed that four patients had worsening of joint symptoms temporally related to the treatment of the primary disease. Two patients had tenosynovitis involving the fingers leading to deformity. Auto-antibodies were negative in all eight patients and none were HLA B27 positive. Arthrocentesis data was available in two patients and revealed inflammatory synovial fluid. One of the patients underwent synovial biopsy demonstrating chronic synovitis with T and B lymphocytes. Overall, the response to NSAIDs was variable. Sulfasalazine was used in two of the five patients for purposes of steroid sparing with partial benefit.

Conclusion: Rheumatological manifestations have not previously been reported as a major component of the clinical manifestation of WHIM syndrome. We present the first detailed cataloguing of such manifestations in a cohort of WHIM patients. Our finding of a high prevalence of joint findings warrants further study. The etiology of arthritis in WHIM syndrome is unknown but could relate to impaired clearance of infectious organisms associated with arthritis or alternatively, an increased risk for autoimmune disease. The rheumatological management of these patients is challenging due to the underlying immunodeficiency.


Disclosure: A. Subedi, None; S. Banerjee, None; B. Betancourt, None; J. D. Katz, None; P. C. Grayson, None; E. Cho, None; D. Velez, None; P. M. Murphy, None; D. H. McDermott, None.

To cite this abstract in AMA style:

Subedi A, Banerjee S, Betancourt B, Katz JD, Grayson PC, Cho E, Velez D, Murphy PM, McDermott DH. Rheumatic Manifestations of Whim Syndrome [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/rheumatic-manifestations-of-whim-syndrome/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/rheumatic-manifestations-of-whim-syndrome/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology